![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, December 01, 2020 11:43:23 AM
Google search "MACIVIVA" see how this unknown otc SEC Filer microcap, MYMX led a consortium of 5 european companies including Catalent UK (NYSE: CTLT), Bachem (SWX: BANB), to successfully develop this process. This breakthrough platform is currently applied to the company's HIV vaccine in partnership with University of Louisiana, Lafayette's Iberia Research Center under NIH funding as well as its current in-house covid vaccine development program. The company is also in partnership with Baylor College of Medicine and recently with Insel Gruppe AG in developing a covid vaccine. News is imminent on status updates. A potential M&A target, imo.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM